SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-24-000052
Filing Date
2024-03-20
Accepted
2024-03-20 08:04:32
Documents
5
Effectiveness Date
2024-03-20

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_20240320evergreen.htm S-8 83050
2 EX-FILING FEES alpn-ex107_20240320evergre.htm EX-FILING FEES 14476
3 EX-5.1 alpn-ex51_20240320evergreen.htm EX-5.1 7283
4 EX-23.1 alpn-ex231_20240320evergre.htm EX-23.1 2337
5 image01.jpg GRAPHIC 98255
  Complete submission text file 0001626199-24-000052.txt   243768
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278079 | Film No.: 24766346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)